Evidence map›Paper›PMID 41733768›Full record

ArticleMolecular biotechnology2026

Comparative Microbiome Analysis of Rhodiola fastigiata Rhizosphere Versus Bulk Soil in Xizang with Targeted Isolation of Rhizosphere-Derived Functional Strains.

Shuxin Zhou, Yao Yao, Ruiying Yuan, Weihua Chu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shuxin ZhouDepartment of Microbiology and Synthetic Biology, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China.
Yao YaoDepartment of Microbiology and Synthetic Biology, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China.
Ruiying YuanCollege of Medicine, Xizang University, Lhasa, 850000, China. 2627478@qq.com.
Weihua ChuDepartment of Microbiology and Synthetic Biology, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China. chuweihua@cpu.edu.cn.ORCID http://orcid.org/0000-0003-0055-2035

Funding

Priority Academic Program Development of Jiangsu Higher Education Institutions PAPD
6 · The paper itself

Abstract

Rhodiola fastigiata, a critically endangered medicinal plant of the Qinghai-Xizang Plateau, faces severe threats from habitat degradation. This study aimed to support its microbial-assisted conservation by characterizing the rhizosphere microbiome and isolating functional plant growth-promoting (PGP) bacteria. Using high-throughput sequencing of the 16S rRNA gene and ITS region, we found the rhizosphere community to be distinct and enriched in key taxa (e.g., Sphingomonas, Mortierella). Metabolic predictions suggested upregulated stress-adaptive pathways. Crucially, from 126 isolates, we obtained four Bacillus strains that concurrently produce protease, amylase, and cellulase and solubilize phosphate-quantifying a multifunctional PGP profile critical for nutrient-poor soils. These culturable, spore-forming strains provide direct resources for developing synthetic inoculants. Our work bridges microbial ecology with applied biotechnology, delivering both a foundational microbial map and candidate strains to enable the cultivation and conservation of this endangered species in extreme environments.

Indexed as

BacteriaMicrobiotaRhizosphereRhodiolaSoil MicrobiologyHigh-Throughput Nucleotide SequencingPhylogenyRNA, Ribosomal, 16SSoilRNA, Ribosomal, 16SSoil16S rRNA gene sequencingAlpine microorganismsBacillusITS sequencingMicrobial conservationPlant growth-promoting rhizobacteriaRhizosphere microbiomeRhodiola fastigiata

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.